Monomorphic ventricular tachycardia (VT) developed in two patients with cardiac sarcoidosis. Before treatment with prednisolone, technetium or gallium scintigram revealed abnormal accumulation in the heart and bilateral hilar lymph nodes, but programmed electrical stimulation failed to induce VTin either case. Prednisolone was administered and the abnormal accumulation of the scintigra ms disappeared. However, VT became reproducibly inducible, and in one of the patients, transient entrainment was demonstrated in clinical VTmorphology. Defibrillators were implanted in both patients. SomeVTsassociated with cardiac sarcoidosis are due to reentry, and inducibility of VTis not associated with the activity of cardiac sarcoidosis. Even though steroid therapy suppresses the activity of cardiac sarcoidosis, defibrillator implantation is necessary to prevent a possible arrhythmic event during the followup. (Internal Medicine 40: 731-735, 2001) 
Introduction
Ventricular tachyarrhythmia (VT) sometimes occurs in patients with cardiac sarcoidosis and can be a cause of sudden cardiac death (1) (2) (3) . However, it has not been well clarified whether steroid therapy which suppresses the activity of cardiac sarcoidosis can prevent the pacing-induced and spontaneous development of VT. In the two present patients with spontaneous monomorphicVTassociated with cardiac sarcoidosis, no VT was induced during the active phase of cardiac sarcoidosis but VTbecame inducible by programmed extrastimulation after treatment with prednisolone by which the abnormal accumulation of technetium and gallium scintigraphy was resolved in the heart.
Case Report
Case1
The patient was a 26-year-old man having sustained monomorphic VT. In August 2000, he complained of palpitation and VTat the rate of 210 bpmas recorded on the twelve-lead electrocardiogram (ECG). He was admitted to Nagaoka Red Cross Hospital. Hematological and serological examinations showed no abnormalities except for a slightly higher serum ACEof 25 IU//. His twelve-lead ECGshowed normal sinus rhythm and complete right bundle branch block. Chest X-p showed mild cardiomegaly and swelling of bilateral hilar lymph nodes. Twodimensional echocardiogram demonstrated that the basal wall of the left ventrile wasthin and wall motion at that site was akinetic. Color-Doppler study did not show prominent valvular regurgitation. Results of coronary angiogramwere normal, and ejection fraction calculated from the left ventriculogram was 45%. During electrophysiologic (EP) study, AH and HV intervals were 120 and 80 ms, respectively at the basic cycle length of 830 ms. Whensingle premature stimulation at progressively shorter coupling intervals of 10 ms was applied to the right atrium, the AHinterval was progressively prolonged to 240 ms until the pacing site reached the effective refractory period. Atrio-ventricular conduction showed Wenckebachblock at the pacing cycle length of 3 16 ms. To study the inducibility of VT, programmed electrical stimulation consisted of 1-3 extrastimuli and rapid incremental pacing up to 286 ms was attempted at 2 sites of the right ventricle and one site of the left ventricle before and after using isoproterenol, but no VTwas induced (Fig. 1) . He was referred to our hospital for further In our hospital, a gallium scintigram revealed abnormal accumulation in the heart and bilateral hilar lymph nodes (Fig.   2 ). Noncaseating granulomatosis was demonstrated by transbronchial lung biopsy. From these findings, cardiac sarcoidosis was diagnosed. Prednisolone at the dose of 50 mg/ day was started for cardiac sarcoidosis; the dose was tapered by 10 mg every two weeks. At the maintenance dose of 20 mg/ day, the abnormal accumulation of gallium scintigram was eliminated (Fig. 2) , and the serum ACElevel returned to the normal value. Then, the second EP study was performed. When 1-2 ventricular extrastimuli at the coupling interval >180 ms was applied at the right ventricle, polymorphic VTwas reproducibly induced (Fig. 1) . However, clinically documented monomorphicVTwas not reproduced by programmedelectrical stimulation. A defibrillator device was implanted in January 2001.
Case2
The patient was a 49-year-old manhaving sustained monomorphic VT. Since November 1 998, he had complained of faintness and palpitation, and VTat the rate of 250 bpmwas documented on his ECG. Treatment with dl-sotalol (160 mg/day) was effective in preventing spontaneous VTattack, and this drug has been administered since April 1999. He was referred to our hospital for further treatment. On admission to our hospital, hematological and serological examinations showed no abnormalities except for a high serum ACEvalue (58.0 IU//). The twelve-lead ECGshowed normal sinus rhythm and complete right bundle branch block. Chest X-p showed mild cardi-Ventricular Tachyarrhythmia in Cardiac S arcoidosis EP study was performed under treatment with dl-sotalol because spontaneous VThad not recurred after dl-sotalol therapy. At the basic cycle length of 860 ms, AHand HVintervals were 120 and 55 ms, respectively. Whensingle premature stimulation was attempted fromthe right atrium, atrio-ventricular conduction showed AHblock at the coupling interval of 400 ms, and Wenckebach block was observed during the pacing cycle length of 428 ms. Programmed electrical stimulation was attempted as in case 1 but no VT was induced (Fig. 3) . During sinus rhythm, endocardial mapping was performed, but no abnormal local electrogram was recorded from either of the ventricles. Prednisolone (40 mg/day) was started for cardiac sarcoidosis, but sustained VT with two different QRSmorphologies recurred although the abnormal technetium accumulation in the heart was eliminated by prednisolone therapy. A temporal pacing lead was inserted to the apex of the right ventricle, and EP study was performed using the lead. These two VTs were reproducibly induced by ventricular extrastimulus, and constant and progressive fusion were demonstrated in one of the VTmorphologies (4, 5) . Thus the mechanism of the VT was considered to be reentry with an excitable gap (5, 6). The spontaneous recurrence of VTbecameinfrequent and finally disappeared during maintenance treatment with prednisolone (20 mg/day). A defibrillator device was implanted in August 1999 but monomorphic VTwas still inducible by programmed electrical stimulation from the device (Fig. 3) .
Discussion
Spontaneous VT which develops in patients with cardiac sarcoidosis is considered to be a manifestation of disease activities or inflammation ( 1-3). Abnormal automaticity or reentry seems to be the mechanismof the VT, but electrophysiological characteristics of VTassociated with cardiac sarcoidosis have not yet been clarified. In the present two patients, monomorphicsustained VTdeveloped during the active phase of cardiac sarcoidosis, and EP study was performed both at the active and then later inactive period. Although no VT was induced at the first EP study, VTs showing clinical and non-clinical QRSmorphologies were reproducibly induced by pro- grammed extrastimulation during the inactive period of cardiac sarcoidosis. Further, in the second patient, transient entrainment was confirmed in clinical VT-morphology (4, 5) . These findings suggested that reentry was the most likely mechanismof these VTs induced during the inactive phase of cardiac sarcoidosis, but monomorphicVT in the first patient might have been due to abnormal automaticity because both EP studies failed to induce the same monomorphic VT. Except for prednisolone, the medication was the same at the first and second EP studies in each patient. Although the precise reasons for the different inducibility of VT in the two EP studies remain uncertain, the possible formation of fibrosis and/or granulomatosis in the myocardiumof the cardiac sarcoidosis, alteration of the conduction property by the use of prednisolone or widening of an excitable gap in the reentry circuit might be related to the pacing-induced VTduring the inactive phase of cardiac sarcoidosis. Since reentrant monomorphicVToriginating from stable organic heart diseases is usually reproduced by programmed electrical stimulation, EP-guided therapy which prevents the induction of VTis considered effective to suppress the clinical recurrence of the VT (7, 8) . However, in patients with cardiac sarcoidosis, the results of EPstudy seem unable to predict the long-term efficacy of the treatment because the inducibility of VT is different in each period of cardiac sarcoidosis, and VT may recur during maintenance treatment with steroids even whenthe activity of cardiac sarcoidosis is successfully suppressed. Furthermore the activity of cardiac sarcoidosis can be variable in spite of the maintenance therapy with steroids which would affect the arrhythmogenicity for VT (1) (2) (3) . Therefore, for VTassociated with cardiac sarcoidosis, it is necessary to consider defibrillator implantation as desirable treatment to Ventricular Tachyarrhythmia in Cardiac Sarcoidosis prevent the recurrence of possible arrhythmic events and sudden cardiac death.
